Artivion (AORT) EBT Growth (5y) (2015 - 2026)
Artivion (AORT) EBT Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn |
| 10 | Artivion | 1.37 Bn | 1.29 Bn | 80.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -39.90% |
| Mar 31, 2026 | 15.72% |
| Dec 31, 2025 | 135.90% |
| Sep 30, 2025 | 29.82% |
| Jun 30, 2025 | 22.25% |
| Mar 31, 2025 | 22.36% |
| Dec 31, 2024 | -66.33% |
| Sep 30, 2024 | -5.00% |
| Jun 30, 2024 | -23.61% |
| Mar 31, 2024 | 57.68% |
| Dec 31, 2023 | 16.53% |
| Sep 30, 2023 | -45.26% |
| Jun 30, 2023 | -81.74% |
| Mar 31, 2023 | -5.25% |
| Dec 31, 2022 | 27.70% |
| Sep 30, 2022 | -259.29% |
| Jun 30, 2022 | -22.84% |
| Mar 31, 2022 | -27.68% |
| Dec 31, 2021 | -47.55% |
| Sep 30, 2021 | 10.92% |